HIV / AIDS in the News

Zimbabwe rejects 'lopsided' US health aid deal over data concerns - BBC

 

CROI 2026: Neurodegeneration, the challenge of aging with HIV - bioworld.com

 

Meghalaya has highest HIV caseload in India, says Health Minister - The Hindu

 

Oropharyngeal cancer is becoming more common in heterosexual men with HIV - Aidsmap

 

Catholic nuns serve on the front lines of Vietnam's shifting HIV crisis - ucanews.com

 

US to end health aid to Zimbabwe after funding talks collapse - 95.5 WSB

 

At-home HIV care cuts new infections by 70%, research finds - Semafor

 

Breakthrough anti-HIV drug "lenacapavir" by Gilead Sciences deployed in African countries - BioSpectrum Asia

 

Battle Lines: Drugs HIV and gangs the Pacific island paradise hit by a triple epidemic - The Telegraph

 

Meghalaya HIV Surge: More Than 10,000 People Receiving Treatment - NDTV

 

The Lancet Respiratory Medicine: Three reasons why the European region should worry about TB - European AIDS Treatment Group

 

FDOH cannot remain silent on HIV medicine crisis | Opinion - Tallahassee Democrat

 

WCC participates in conference on “Rethinking Health Systems for Africa’s Future: Faith, Innovation, and Sustainability” - World Council of Churches

 

Global HIV/AIDS Overview - HIV.gov

 

Florida uses emergency rule to cut patients off AIDS medication - Tampa Bay Times

 

HIV Treatment as Prevention: TASP Prevention of HIV/AIDS - HIV.gov

 

Preventing Sexual Transmission of HIV - hiv.gov

 

Switch to single-tablet bictegravir–lenacapavir from a complex HIV regimen (ARTISTRY-1): a randomised, open-label, phase 3 clinical trial - The Lancet

 

HIV & AIDS Trends and U.S. Statistics Overview - HIV.gov

 

Socioeconomic Factors Linked to COVID-19 Hospitalization in Women With HIV - Infectious Disease Advisor

 

Switch to DOR/ISL Maintains HIV-1 Virologic Suppression at 96 Weeks - Infectious Disease Advisor

 

Ibalizumab Yields Durable Virologic Suppression in Multidrug-Resistant HIV-1 - Infectious Disease Advisor

 

[Report] Alliance for Public Health: 25 Years of Lifesaving Impact. Four Years of Resilience in Wartime - European AIDS Treatment Group

 

Researchers uncover vulnerabilities in elusive HIV reservoir clones - News-Medical

 

The Lancet Global Health: The tuberculogenic environment - European AIDS Treatment Group

 

[CROI 2026] MedPage Today: Semaglutide not linked to depression symptoms in people with HIV - European AIDS Treatment Group

 

[CROI 2026] MedPage Today: Study documents dramatic rise of throat cancer in people with HIV - European AIDS Treatment Group

 

[CROI 2026] AJMC: Sustained HIV viral suppression restores immune potential - European AIDS Treatment Group

 

Innovative Approaches Target HIV’s Final Strongholds - Bioengineer.org

 

Scientists confirm HIV capsid is a good drug target despite resistance - The Hindu